title: Therapy of myelodysplastic syndromes: advances and perspectives. Innsbruck, Austria, October 7-10, 1990.
authors.affiliation: Universitätsklinik für Innere Medizin, Innsbruck, Austria.
authors.forename: H
authors.initials: H
authors.lastname: Zwierzina
authors.forename: G J
authors.initials: GJ
authors.lastname: Mufti
authors.forename: F
authors.initials: F
authors.lastname: Schmalzl
mesh_terms: D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000627:therapeutic use; D004920:Erythropoiesis / Q000502:physiology; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D006410:Hematopoiesis / Q000502:physiology; D007375:Interleukin-1 / Q000502:physiology; D015850:Interleukin-6 / Q000502:physiology; D009190:Myelodysplastic Syndromes / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*
chemical_list: D007375:Interleukin-1; D015850:Interleukin-6; D003561:Cytarabine; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor